My Mother Had Alzheimer’s. That’s Why I Started a GLP-1

As an endocrinologist, I spend much of my day discussing GLP-1 medications with my patients. This week, I became one of those patients myself.My decision wasn’t about weight loss. If anything, I’d prefer not to lose weight. At 48 years old, I’m comfortable where I am, and I know that losing too much weight, particularly in my face, would not be something I’d welcome.My motivation was something far more personal.Witnessing a Mother’s Illness My mother developed subtle memory problems in her early sixties. As a physician, I recognized the signs of mild cognitive impairment before many others did. I’ll never forget sobbing one morning as I prepared to round on patients during residency when I realized my mother had forgotten my birthday. Caroline Messer, MDOver the next decade, I watched Alzheimer’s disease slowly take away the brilliant woman who was my best friend. She ultimately died at age 74 with end-stage dementia.Watching that progression was the most heartbreaking experience of my life. My father and I lived through every stage together, from the first hints that something was wrong to the devastating realization that the woman we both adored was gradually disappearing. We watched Alzheimer’s steal her memory, her independence, her personality, and eventually her ability to recognize us. It wasn’t just my mother who suffered. The disease consumed our entire family.That experience fundamentally changed how I think about prevention. I have an amazing husband and four wonderful children. If there’s even a possibility that I can reduce the chance they’ll someday experience what my father and I endured, I feel compelled to explore it. I recognize that this decision is based on evolving science rather than definitive proof. But those of us with a strong family history don’t always feel we have the luxury of waiting 20 years for perfect data before making decisions that could matter decades from now.Why I’m Taking a GLP-1 So why start a GLP-1?The honest answer is that I don’t know whether it will help. No one does. Currently, no data are available showing that GLP-1 medications prevent Alzheimer’s disease, and there are certainly no data proving that orforglipron is superior to any other GLP-1 for that purpose. But when I look at the totality of the evidence, I see a class of medications with a physiologically plausible rationale and an expanding list of benefits across multiple organ systems.Researchers have identified GLP-1 receptors throughout the brain, and laboratory studies suggest that activating them may reduce neuroinflammation, improve insulin signaling within the brain, support mitochondrial function, strengthen the blood-brain barrier, improve cerebral blood flow, and reduce accumulation of amyloid-beta and tau proteins. None of these findings proves that GLP-1 therapy prevents dementia in humans, but together they provide a compelling scientific foundation for asking the question.Observational studies have also been encouraging. Across multiple populations, people with diabetes treated with GLP-1 receptor agonists have consistently shown lower rates of dementia than those receiving many other glucose-lowering medications. These studies cannot establish causality, as healthier patients may be more likely to receive GLP-1 therapy in the first place, but the consistency of the findings is difficult to ignore.Randomized clinical trials are now beginning to emerge. Some have shown encouraging signals, including slower brain atrophy, while others have not demonstrated significant cognitive benefits in patients with early Alzheimer’s disease. That doesn’t necessarily mean these medications won’t work. Preventing Alzheimer’s decades before symptoms develop may be very different from treating established disease.How I Chose My GLP-1 One of the reasons I chose orforglipron specifically is that it isn’t a peptide at all. Unlike semaglutide or tirzepatide, which are large peptide molecules weighing more than 4000 Da, orforglipron is a true small molecule weighing about 883 Da, making it roughly five times smaller. That small size is one reason it can be taken as a simple oral pill without injections, fasting, or absorption enhancers. It also raises an intriguing scientific question. Small molecules often distribute into tissues differently than large peptides, including potentially into the central nervous system. Whether that translates into greater penetration of the brain or ultimately greater protection against Alzheimer’s disease is completely unknown, and there are no clinical data demonstrating that it does. Still, from a biological standpoint, I find the hypothesis compelling enough that it influenced my personal decision.Even if that hypothesis ultimately proves wrong, I still see potential upsides. GLP-1 medications have already demonstrated meaningful cardiovascular and kidney benefits, reductions in liver fat, improvements in metabolic health, and decreases in systemic inflammation. Researchers are now studying their potential role in conditions ranging from Parkinson’s disease to osteoarthritis. In just a few years, these medications have evolved from treatments primarily associated with diabetes and weight loss into therapies that may influence multiple aspects of aging and chronic disease.Living With Uncertainty Could I be wrong? Absolutely. Twenty years from now, we may learn that GLP-1 medications have little effect on dementia risk. On the other hand, we may discover that the timing of initiating treatment — decades before symptoms appear — was the critical factor. Unfortunately, none of us has the luxury of waiting 20 years before making decisions about our own health.For me, the potential benefits outweigh the risks. That doesn’t mean everyone should make the same choice. This is a deeply personal decision based on my family history, my own risk tolerance, and my interpretation of an evolving body of scientific evidence. In the meantime, I’ll continue prioritizing protein, lifting weights, and doing everything I can to preserve muscle, hoping that years from now I’ll look back and conclude this was one of the better bets I ever made.